Oral Manifestations
Conditions
Brief summary
This study is 25 days long. People participating in this study will be asked to brush their teeth two times a day. People will be assigned to a mouthwash and will rinse four times a day at the site for five days. A dentist or dental hygienist will look at the mouth, teeth, tongue and gums to make sure the mouthwash does not irritate the mouth. After Day 5 of the study, people will continue to brush two times a day and will return on Day 24 to have their mouth looked at again. People without irritation in their mouth will rinse 4 times a day at the clinical site. People will return to the clinical site the next day and have a final oral exam in which the dentist or dental hygienist will look at the mouth for irritation.
Detailed description
This is a randomized, observer-blind, single-center, supervised, controlled, parallel-designed study. Approximately 90 generally healthy adults meeting the necessary inclusion/exclusion criteria will be enrolled so that 78 subjects (26 per treatment group) would reasonably be expected to complete the study. Subjects will have their oral soft/hard tissues assessed at Screening (visit 1), Baseline (visit 2), and Days 3, 5, 24, and 25 (visits 4,6-8). During the first week of the study, subjects will be instructed to brush their teeth for one minute in their usual manner, twice daily using the provided standard fluoride toothpaste. Subjects will return for the Baseline exam and, upon qualification with entry criteria, will be assigned to one of three treatment groups. Qualified subjects will be instructed to return to the site for five consecutive days. Subjects will have four supervised rinses with their assigned mouth rinse for either 30 or 60 seconds using 10 ml or 20 ml, at subsequent one-hour intervals. During the 5 consecutive days of exposure to the assigned mouthrinse, subjects will brush their teeth using the provided fluoride-free toothpaste and soft-bristled toothbrush. Subjects will then have an 18-day rest period (off treatment). During this time, subjects will follow their usual oral hygiene and dietary habits, using the standard fluoride toothpaste and soft toothbrush provided, and must refrain from using any unassigned oral care products. On the 19th day after completion of Day 5 (Day 24), subjects will return for an oral examination. If no pathology is present, subjects will be given a challenge treatment (four supervised rinses) and the final oral examination will be performed on Day 25.
Interventions
DEVICEPotassium Oxalate without Fluoride
1.40% Potassium Oxalate Sensitive Mouthwash without fluoride - Rinse with 10ml for 60 seconds, four times daily successively at 1 hour intervals for five days
DEVICEPotassium Oxalate with Fluoride
1.40% Potassium Oxalate Sensitive Mouthwash with fluoride - Rinse with 20ml for 60 seconds, four times daily successively at 1 hour intervals for five days
DEVICEActive Comparator PO-116-A
Rinse with comparator mouthwash 20ml for 30 seconds, four times daily successively at 1 hour intervals for five days
Sponsors
Johnson & Johnson Consumer and Personal Products Worldwide
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Males and females at least 18 years of age in good general and oral health without any known allergy to commercial dental products or cosmetics. * Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial. * Willingness to use the assigned products according to instructions, availability for appointments, and likelihood of completing the clinical trial. * Willingness to refrain from using any breath freshener products (e.g., oral care strips, candy-type mints, sprays, chewing gums, throat lozenges, cough drops or mouthwashes), whitening products and smokeless tobacco products within one week prior to and for the duration of the study, in order to reduce alternate sources of potential irritation and sensitization. * A minimum of 20 natural teeth. * Absence of abnormal or severe fissured tongue, geographic tongue, or any obvious tongue abnormalities that may interfere with the assessment of oral irritation. * Adequate oral hygiene (i.e., brush teeth daily & exhibit no signs of oral neglect). * Absence of neglected dental health (i.e., gross calculus deposits or rampant caries based on visual examination), significant oral soft tissue pathology, systematically-related gingival enlargement or tissue damage due to ill-fitting appliances or restoration. * Absence of orthodontic bands, appliances, bridges, extensive large restorations or removable orthodontic appliances.
Exclusion criteria
* Volunteers who report history or presence of kidney disorders or kidney stones, Crohn's Disease or other malabsorption syndromes. * History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthwashes. * Physical limitations or restrictions that might preclude use of normal oral hygiene procedures (i.e., toothbrushing, mouthrinsing, etc.). * History or current evidence of significant oral soft tissue pathology, excluding gingivitis, based on the dentist's visual examination and at the discretion of the investigator. * Those requiring antibiotic premedication prior to dental treatment. * Participation in a dental clinical trial involving oral care products within the past 30 days. * Visual evidence of Moderate/Advanced Periodontitis (ADA Type III, IV). * Women who are pregnant, nursing or plan to become pregnant during the course of the study. * Volunteers requiring treatment with Indinavir or loop diuretics (i.e., Furosemide). * Other severe, acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or may interfere with the interpretation of trial result and, in the judgment of the investigator, would make the subject inappropriate for entry into this trial * Any clinical history which in the opinion of the investigator could compromise the safety of the subject or the clinical parameters being assessed
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Screening | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Day 1 - Post-treatment | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Day 3 | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Day 5 | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Day 24 - Pretreatment | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Day 24 - Post-treatment | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Day 25 | Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal. |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Screening | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Day 1 - Baseline/Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Day 1 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Day 3 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Day 5 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Day 24 - Pretreatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Day 24 - Post-treatment | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
| Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Day 25 | The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe). |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| 19292-116-A Control (Listerine®) Cool Mint® Listerine® Antiseptic Mouth Rinse (20 mL) | 27 |
| 12027-019 1.40% Potassium Oxalate Mouth Rinse without Fluoride (10 mL) | 26 |
| 12027-020 1.40% Potassium Oxalate Mouth Rinse with Fluoride (20 mL) | 27 |
| Total | 80 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Adverse Event | 1 | 0 | 1 |
| Overall Study | Withdrawal by Subject | 0 | 0 | 3 |
Baseline characteristics
| Characteristic | 19292-116-A Control (Listerine®) | 12027-019 | 12027-020 | Total |
|---|---|---|---|---|
| Age, Continuous | 48.4 years STANDARD_DEVIATION 14.24 | 37.6 years STANDARD_DEVIATION 14.29 | 51.0 years STANDARD_DEVIATION 15.03 | 45.8 years STANDARD_DEVIATION 15.47 |
| Region of Enrollment USA | 27 participants | 26 participants | 27 participants | 80 participants |
| Sex: Female, Male Female | 20 Participants | 15 Participants | 22 Participants | 57 Participants |
| Sex: Female, Male Male | 7 Participants | 11 Participants | 5 Participants | 23 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — |
| other Total, other adverse events | 0 / 27 | 0 / 26 | 0 / 27 |
| serious Total, serious adverse events | 0 / 27 | 0 / 26 | 0 / 27 |
Outcome results
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Buccal Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Dental Restorations | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Tongue | 3.7 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Tongue | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Buccal Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Gingiva | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Tongue | 3.7 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment | Teeth | 0 Percentage of Participants |
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Day 1 - Post-treatment
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Buccal Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Tongue | 18.5 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Teeth | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Tongue | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Gingiva | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Tongue | 7.7 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Buccal Mucosa | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment | Sublingual Mucosa | 0 Percentage of Participants |
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Day 24 - Post-treatment
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Buccal Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Tongue | 15.4 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Teeth | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Tongue | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Gingiva | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Tongue | 4.3 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Buccal Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment | Sublingual Mucosa | 0 Percentage of Participants |
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Day 24 - Pretreatment
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Buccal Mucosa | 3.7 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Tongue | 3.7 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Teeth | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Tongue | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Gingiva | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Tongue | 4.3 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Buccal Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment | Sublingual Mucosa | 0 Percentage of Participants |
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Day 25
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Buccal Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Tongue | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Teeth | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Tongue | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Gingiva | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Tongue | 4.3 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Buccal Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25 | Sublingual Mucosa | 0 Percentage of Participants |
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Day 3
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Buccal Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Tongue | 25.9 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Teeth | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Tongue | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Gingiva | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Tongue | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Buccal Mucosa | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3 | Sublingual Mucosa | 0 Percentage of Participants |
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Day 5
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Buccal Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Tongue | 22.2 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Teeth | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Tongue | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Gingiva | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Tongue | 4.0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Buccal Mucosa | 4.0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5 | Sublingual Mucosa | 0 Percentage of Participants |
Primary
Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined. The dental examiner evaluated any condition as either normal or abnormal.
Time frame: Screening
Population: Analysis was based on subjects with measurements for this variable.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Buccal Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Labial Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Sublingual Mucosa | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Mucobuccal Fold | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Gingiva | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Tongue | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Hard/Soft Palate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Uvula/Oropharynx | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Teeth | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Teeth | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Buccal Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Tongue | 3.8 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Gingiva | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Labial Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Dental Restorations | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Sublingual Mucosa | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-019 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Mucobuccal Fold | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Uvula/Oropharynx | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Mucobuccal Fold | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Gingiva | 3.7 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Tongue | 3.7 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Teeth | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Hard/Soft Palate | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Buccal Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Dental Restorations | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Labial Mucosa | 0 Percentage of Participants |
| 12027-020 | Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening | Sublingual Mucosa | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Mild | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment | None | 96.2 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | None | 96.3 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Moderate | 3.7 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Mild | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3 | None | 96.2 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Mild | 4.0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5 | None | 96.0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 25 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 3 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Day 5 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Gingiva at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Gingiva at Screening | Severe | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | None | 96.2 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Mild | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25 | Severe | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | None | 96.3 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Mild | 3.7 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | None | 96.3 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Mild | 3.7 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Mild | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment | None | 96.2 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 25 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 3 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Day 5 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Tongue at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | None | 96.2 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Mild | 3.8 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Tongue at Screening | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Baseline/Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 1 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Post-treatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 24 - Pretreatment
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 25
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 3
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Day 5
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5 | None | 100 Percentage of Participants |
Primary
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
Time frame: Screening
Population: Analysis was based on the Full Analysis Set, defined as all randomized participants who used the investigational product. No imputations were made for missing data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | None | 100 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Mild | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Moderate | 0 Percentage of Participants |
| 19292-116-A Control (Listerine®) | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Severe | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | None | 100 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Moderate | 0 Percentage of Participants |
| 12027-019 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Severe | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Mild | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | Moderate | 0 Percentage of Participants |
| 12027-020 | Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening | None | 100 Percentage of Participants |